Systacare Remedies

You Tube Google Plus Facebook


Methylprednisolone Sodium Succinate Injection

Methylprednisolone Sodium Succinate Injection

Name of the medicinal product

  • Methylprednisolone 40mg / 125 mg / 500 mg /1000 mg  for injection/infusion

 

Pharmaceutical form

  • Powder for injection/infusion.
  • Each vial of methylprednisolone sodium succinate contains a white or almost white amorphous powder.


Clinical particulars
Therapeutic indications

Methylprednisolone powder is indicated to treat any condition in which rapid and intense corticosteroid effect is required such as:


Dermatological disease

  • Severe erythema multiforme (Stevens Johnson syndrome)


 Allergic states

  • Bronchial asthma
  • Severe seasonal and perennial allergic rhinitis
  • Angioneurotic oedema
  • Anaphylaxis


Gastro intestinal diseases

  • Ulcerative colitis
  • Crohn's disease


Respiratory diseases

  • Aspiration of gastric contents
  • Fulminating or disseminated tuberculosis (with appropriate antituberculous chemotherapy)


Neurological disorders

  • Cerebral oedema secondary to cerebral tumour
  • Acute exacerbations of multiple sclerosis superimposed on a relapsing/remitting background.


Miscellaneous

  • T.B. meningitis (with appropriate antituberculous chemotherapy)
  • Transplantation